1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Pharmaceuticals in Mexico
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
5 Pharmaceuticals in The United States
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Company Profiles
6.1. Johnson & Johnson
6.2. Pfizer Inc.
6.3. Apotex, Inc.
6.4. Merck & Co., Inc.
6.5. Sanofi SA
6.6. Genomma Lab Internacional SAB de CV
6.7. AstraZeneca PLC
7 Appendix
7.1. Methodology
7.2. About the Publisher
List of Tables
Table 1: NAFTA countries pharmaceuticals industry, revenue ($bn), 2016-25
Table 2: NAFTA countries pharmaceuticals industry, revenue ($bn), 2016-20
Table 3: NAFTA countries pharmaceuticals industry forecast, revenue ($bn), 2020-25
Table 4: Canada pharmaceuticals market value: $ billion, 2016-20
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2020
Table 6: Canada pharmaceuticals market share: % share, by value, 2020
Table 7: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Table 8: Canada size of population (million), 2016-20
Table 9: Canada GDP (constant 2005 prices, $ billion), 2016-20
Table 10: Canada GDP (current prices, $ billion), 2016-20
Table 11: Canada inflation, 2016-20
Table 12: Canada consumer price index (absolute), 2016-20
Table 13: Canada exchange rate, 2016-20
Table 14: Mexico pharmaceuticals market value: $ billion, 2016-20
Table 15: Mexico pharmaceuticals market geography segmentation: $ billion, 2020
Table 16: Mexico pharmaceuticals market share: % share, by value, 2020
Table 17: Mexico pharmaceuticals market value forecast: $ billion, 2020-25
Table 18: Mexico size of population (million), 2016-20
Table 19: Mexico GDP (constant 2005 prices, $ billion), 2016-20
Table 20: Mexico GDP (current prices, $ billion), 2016-20
Table 21: Mexico inflation, 2016-20
Table 22: Mexico consumer price index (absolute), 2016-20
Table 23: Mexico exchange rate, 2016-20
Table 24: United States pharmaceuticals market value: $ billion, 2016-20
Table 25: United States pharmaceuticals market geography segmentation: $ billion, 2020
Table 26: United States pharmaceuticals market share: % share, by value, 2020
Table 27: United States pharmaceuticals market value forecast: $ billion, 2020-25
Table 28: United States size of population (million), 2016-20
Table 29: United States GDP (constant 2005 prices, $ billion), 2016-20
Table 30: United States GDP (current prices, $ billion), 2016-20
Table 31: United States inflation, 2016-20
Table 32: United States consumer price index (absolute), 2016-20
Table 33: United States exchange rate, 2016-20
Table 34: Johnson & Johnson: key facts
Table 35: Johnson & Johnson: Annual Financial Ratios
Table 36: Johnson & Johnson: Key Employees
Table 37: Johnson & Johnson: Key Employees Continued
Table 38: Pfizer Inc.: key facts
Table 39: Pfizer Inc.: Annual Financial Ratios
Table 40: Pfizer Inc.: Key Employees
Table 41: Pfizer Inc.: Key Employees Continued
Table 42: Apotex, Inc.: key facts
Table 43: Apotex, Inc.: Key Employees
Table 44: Merck & Co., Inc.: key facts
Table 45: Merck & Co., Inc.: Annual Financial Ratios
Table 46: Merck & Co., Inc.: Key Employees
Table 47: Merck & Co., Inc.: Key Employees Continued
Table 48: Sanofi SA: key facts
Table 49: Sanofi SA: Annual Financial Ratios
Table 50: Sanofi SA: Key Employees
Table 51: Sanofi SA: Key Employees Continued
Table 52: Genomma Lab Internacional SAB de CV: key facts
Table 53: Genomma Lab Internacional SAB de CV: Annual Financial Ratios
Table 54: Genomma Lab Internacional SAB de CV: Key Employees
Table 55: AstraZeneca PLC: key facts
Table 56: AstraZeneca PLC: Annual Financial Ratios
Table 57: AstraZeneca PLC: Key Employees
List of Figures
Figure 1: NAFTA countries pharmaceuticals industry, revenue ($bn), 2016-25
Figure 2: NAFTA countries pharmaceuticals industry, revenue ($bn), 2016-20
Figure 3: NAFTA countries pharmaceuticals industry forecast, revenue ($bn), 2020-25
Figure 4: Canada pharmaceuticals market value: $ billion, 2016-20
Figure 5: Canada pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 6: Canada pharmaceuticals market share: % share, by value, 2020
Figure 7: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Figure 8: Forces driving competition in the pharmaceuticals market in Canada, 2020
Figure 9: Drivers of buyer power in the pharmaceuticals market in Canada, 2020
Figure 10: Drivers of supplier power in the pharmaceuticals market in Canada, 2020
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2020
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2020
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2020
Figure 14: Mexico pharmaceuticals market value: $ billion, 2016-20
Figure 15: Mexico pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 16: Mexico pharmaceuticals market share: % share, by value, 2020
Figure 17: Mexico pharmaceuticals market value forecast: $ billion, 2020-25
Figure 18: Forces driving competition in the pharmaceuticals market in Mexico, 2020
Figure 19: Drivers of buyer power in the pharmaceuticals market in Mexico, 2020
Figure 20: Drivers of supplier power in the pharmaceuticals market in Mexico, 2020
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2020
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2020
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2020
Figure 24: United States pharmaceuticals market value: $ billion, 2016-20
Figure 25: United States pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 26: United States pharmaceuticals market share: % share, by value, 2020
Figure 27: United States pharmaceuticals market value forecast: $ billion, 2020-25
Figure 28: Forces driving competition in the pharmaceuticals market in the United States, 2020
Figure 29: Drivers of buyer power in the pharmaceuticals market in the United States, 2020
Figure 30: Drivers of supplier power in the pharmaceuticals market in the United States, 2020
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2020
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2020
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2020
